Mesenchymal stem cells overexpressing CYP46A1 inhibit lipopolysaccharide-induced lipid accumulation and neuroinflammation in N9 microglial cells
Cholesterol redistribution triggered by CYP46A1 gene therapy improves major hallmarks of Niemann-Pick type C disease but is not sufficient to halt neurodegeneration